TRIMETHOPRIM (trimethoprim) by PharmaIN is dihydrofolate reductase inhibitors [moa]. First approved in 1986.
Drug data last refreshed 19h ago
Dihydrofolate Reductase Inhibitors
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Trimethoprim/Sulfamethoxazole Combined With Caspofungin as First-line Therapy in PCP
Short and Long Term Outcomes of Doxycycline Versus Trimethoprim-Sulfamethoxazole for Skin and Soft Tissue Infections Treatment
PK of Clindamycin and Trimethoprim-sulfamethoxazole in Infants and Children
Drug-drug Interaction Study of GSK1278863 With Pioglitazone, Rosuvastatin and Trimethoprim in Healthy Adult Volunteers
Daily Trimethoprim-sulfamethoxazole or Weekly Chloroquine Among Adults on ART in Malawi
Worked on TRIMETHOPRIM at PharmaIN? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.